Jesper Reibel

Jesper Reibel

Professor, emeritus


  1. 2011
  2. Published

    Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial

    Pedersen, Anne Marie Lynge, Asmussen, K., Holm, Lars Morten, Reibel, Jesper & Jacobsen, Søren, Sep 2011.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  3. Published

    Primary Sjögren's syndrome: Rituximab Restores Salivary Gland Structure and Function

    Pedersen, Anne Marie Lynge, Jacobsen , S., Asmussen, K., Holm, Lars Morten & Reibel, Jesper, Aug 2011.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. Published
  5. Published
  6. Published

    Increased salivary secretory immunoglobulin A five years after moderate-dose adjuvant chemotherapy and antihormone treatment in breast cancer patients

    Jensen, S. B., Kragelund, C., Dynesen, A. W., Mouridsen, H. T., Reibel, Jesper & Nauntofte, B., 2011. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  7. Published

    Moderate-dose adjuvant chemotherapy temporarily impairs oral health-related quality of life

    Jensen, S. B., Kragelund, C., Dynesen, A. W., Mouridsen, H. T., Reibel, Jesper & Nauntofte, B., 2011. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

ID: 13110